Font Size About Us Products Research Responsibility Investor Relations Contact Us News & Media Careers Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree SEEING COMPLEXITY IN A NEW LIGHT Where others see complexity, we see value for patients and shareholders About Us Careers Pipeline Managing Complexity. Improving Lives. News & Media Mallinckrodt Presents Results on Real World Treatment Patterns and Outcomes in Hospitalized Patients with Esophageal Variceal Hemorrhage and Liver Cirrhosis Treated with Terlipressin at the American College of Gastroenterology Annual Scientific Meeting Mallinckrodt Presents Results from Two Retrospective Studies on Real World Characteristics and Outcomes of Patients with Hepatorenal Syndrome Type-1 (HRS-1) at The Liver Meeting Digital Experience COVID-19 Resources We are so grateful for all first responders, healthcare professionals and essential employees' efforts in the battle against COVID-19. We believe in listening to needs and delivering solutions and we are proud to join you in the fight. We are doing a variety of things to make a difference. Learn More Financial Restructuring We are taking important actions to strengthen our financial position and resolve a range of legal liabilities. For additional information and disclosures, please visit www.advancingmnk.com Read More A Diverse and Growing Pipeline Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development. View Our Pipeline Corporate Social Responsibility Report Mallinckrodt releases its first annual Corporate Social Responsibility report that illustrates a wide-ranging commitment to corporate stewardship. Read More Inclusion & Diversity We are strengthened by the value we derive from the varied identities, experiences, cultures and views of our employees. Our Commitment Mallinckrodt's Pledge on Drug Pricing and Innovation We pledge to create the best possible healthcare at the lowest possible cost for the greatest number of people. Our Pledge Our Products Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace. Get Product Information Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2021 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Resources For: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure